Literature DB >> 28088736

LncRNA CCAT2 promotes tumorigenesis by over-expressed Pokemon in non-small cell lung cancer.

Zhihong Zhao1, Ju Wang2, Shengfa Wang2, Hao Chang2, Tiewa Zhang2, Junfeng Qu2.   

Abstract

BACKGROUND: Non-small cell lung cancer (NSCLC) remains one of the most important death-related diseases, with poor effective diagnosis and less therapeutic biomarkers. LncRNA colon cancer-associated transcript 2 (CCAT2) was identified as an oncogenic lncRNA and over-expressed in many tumor cells. The aims of this study were to detect the correlation between CCAT2 and its regulatory genes and then explore the potential mechanism between them in NSCLC.
METHODS: In this study, qRT-PCR was used to detect CCAT2, Pokemon and p21 expression. Western-blot was used to detect protein levels of Pokemon and p21. CCK-8 assay and Transwell chambers were used to assess cell viability and invasion.
RESULTS: CCAT2 and Pokemon were over-expressed in NSCLC tissue and cells. In NSCLC cells, CCAT2 knockdown significantly decreased cell viability and invasion as well as Pokemon expression, but increased the expression of p21; then CCAT2 overexpression revealed an opposite result. In addition, over-expressed Pokemon reversed the results that induced by si-CCAT2, while down-regulation of Pokemon significantly reversed the results that induced by CCAT2 overexpression.
CONCLUSION: The results indicated that CCAT2 promotes tumorigenesis by over-expression of Pokemon, and the potential mechanism might relate to the Pokemon related gene p21.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CCAT2; Cell viability and invasion; Non-small cell lung cancer; Pokemon; p21

Mesh:

Substances:

Year:  2017        PMID: 28088736     DOI: 10.1016/j.biopha.2016.12.122

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  25 in total

1.  Long non-coding RNA-CCAT2 promotes the occurrence of non-small cell lung cancer by regulating the Wnt/β-catenin signaling pathway.

Authors:  Chengling Zhao; Chenchen Qiao; Liguo Zong; Yuqing Chen
Journal:  Oncol Lett       Date:  2018-07-23       Impact factor: 2.967

2.  Long noncoding RNA CASC15 predicts unfavorable prognosis and exerts oncogenic functions in non-small cell lung cancer.

Authors:  Min Li; Yu Chen; Jicun Zhu; Zhan Gao; Tao Wang; Pengli Zhou
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

3.  LncRNA ATB promotes the proliferation and metastasis of lung cancer via activation of the p38 signaling pathway.

Authors:  Lei Wei; Tao Wu; Ping He; Jun-Lei Zhang; Wei Wu
Journal:  Oncol Lett       Date:  2018-07-10       Impact factor: 2.967

Review 4.  Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy.

Authors:  Valentina Foglizzo; Serena Marchiò
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

5.  The Expression of CCAT2, UCA1, PANDA and GHET1 Long Non-coding RNAs in Lung Cancer.

Authors:  Farbod Esfandi; Hamid Fallah; Shahram Arsang-Jang; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Rep Biochem Mol Biol       Date:  2019-04

6.  LncRNA GAS6-AS2 promotes non-small-cell lung cancer cell proliferation via regulating miR-144-3p/ MAPK6 axis.

Authors:  Guangjie Hou; Junfeng Yang; Jinxing Tang; Yi He
Journal:  Cell Cycle       Date:  2021-01-18       Impact factor: 4.534

Review 7.  Major Tumor Suppressor and Oncogenic Non-Coding RNAs: Clinical Relevance in Lung Cancer.

Authors:  Kentaro Inamura
Journal:  Cells       Date:  2017-05-09       Impact factor: 6.600

8.  LncRNA CCAT2 promoted osteosarcoma cell proliferation and invasion.

Authors:  Lihua Yan; Xiangkun Wu; Xianzhe Yin; Feng Du; Yongxi Liu; Xunmeng Ding
Journal:  J Cell Mol Med       Date:  2018-03-04       Impact factor: 5.310

Review 9.  Long non-coding RNAs associated with non-small cell lung cancer.

Authors:  Yuting Zhan; Hongjing Zang; Juan Feng; Junmi Lu; Lingjiao Chen; Songqing Fan
Journal:  Oncotarget       Date:  2017-08-09

Review 10.  Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.

Authors:  Richard Heery; Stephen P Finn; Sinead Cuffe; Steven G Gray
Journal:  Cancers (Basel)       Date:  2017-04-21       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.